TGFB3 and systemic sclerosis: Having observed increased TGFβ1 levels at baseline in IPF and SSc fibroblasts and induction of TGFβ2 and TGFβ3 levels by IGF-II, we examined the impact of inhibiting the shared TGFβ receptor on the IGF-II fibrotic response.